Insider: Luly Jay R. President and CEO - ENANTA PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 858,026 | 0 | 858,026 |
| Value | $11,274,461.64 | $0.00 | $11,274,461.64 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 12/05/2025 | DDS | 4,743 | Direct | COM | $14.23 | $67,492.89 | 858,026 |
| 02/12/2025 | AAP | 45,000 | Direct | COM | $5.69 | $256,050.00 | 846,638 |
| 12/05/2023 | DDS | 7,230 | Direct | COM | $9.63 | $69,624.90 | 806,793 |
| 03/13/2023 | DDS | 10,697 | Direct | COM | $44.81 | $479,332.57 | 837,025 |
| 03/13/2023 | DDS | 1,566 | Direct | COM | $46.13 | $72,239.58 | 819,810 |
| 03/13/2023 | DDS | 15,649 | Direct | COM | $45.31 | $709,056.19 | 821,376 |
| 12/16/2022 | DDS | 8,597 | Direct | COM | $44.54 | $382,910.38 | 787,408 |
| 12/16/2022 | DDS | 7,800 | Direct | COM | $43.59 | $340,002.00 | 796,005 |
| 12/16/2022 | DDS | 13,603 | Direct | COM | $45.49 | $618,800.47 | 773,805 |
| 09/15/2021 | DDS | 4,516 | Direct | COM | $59.06 | $266,697.80 | 676,972 |
| 07/06/2018 | DDS | 12,622 | Direct | COM | $124.26 | $1,568,460.21 | 612,427 |
| 07/06/2018 | DDS | 7,538 | Direct | COM | $125.27 | $944,264.91 | 604,889 |
| 07/06/2018 | DDS | 4,125 | Direct | COM | $127.12 | $524,379.08 | 593,026 |
| 07/06/2018 | DDS | 7,738 | Direct | COM | $126.36 | $977,787.61 | 597,151 |
| 07/05/2018 | DDS | 2,977 | Direct | COM | $123.81 | $368,567.78 | 625,049 |
| 05/17/2018 | DDS | 10,968 | Direct | COM | $105.83 | $1,160,742.34 | 628,026 |
| 05/16/2018 | DDS | 14,032 | Direct | COM | $105.82 | $1,484,912.55 | 638,994 |
| 03/09/2015 | DDS | 100 | Direct | COM | $34.88 | $3,487.54 | 476,393 |
| 03/09/2015 | DDS | 11,300 | Direct | COM | $33.13 | $374,374.65 | 480,093 |
| 03/09/2015 | DDS | 3,600 | Direct | COM | $34.07 | $122,658.48 | 476,493 |
| 02/20/2015 | DDS | 15,000 | Direct | COM | $35.35 | $530,289.00 | 491,393 |
| 01/05/2015 | DDS | 4,000 | Direct | COM | $50.97 | $203,894.00 | 506,393 |
| 01/05/2015 | DDS | 11,000 | Direct | COM | $50.23 | $552,568.50 | 510,393 |
| 12/01/2014 | DDS | 2,400 | Direct | COM | $46.97 | $112,727.04 | 514,338 |
| 12/01/2014 | DDS | 1,200 | Direct | COM | $45.96 | $55,152.00 | 516,738 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research